↓ Skip to main content

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Overview of attention for article published in Arthritis Research & Therapy, September 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)
Published in
Arthritis Research & Therapy, September 2020
DOI 10.1186/s13075-020-02305-w
Pubmed ID
Authors

Casper Webers, Carmen Stolwijk, Olga Schiepers, Thea Schoonbrood, Astrid van Tubergen, Robert Landewé, Désirée van der Heijde, Annelies Boonen

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 16%
Researcher 6 14%
Student > Doctoral Student 3 7%
Professor 3 7%
Student > Postgraduate 2 5%
Other 3 7%
Unknown 20 45%
Readers by discipline Count As %
Medicine and Dentistry 13 30%
Veterinary Science and Veterinary Medicine 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Neuroscience 2 5%
Agricultural and Biological Sciences 1 2%
Other 1 2%
Unknown 23 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2020.
All research outputs
#16,733,516
of 25,387,668 outputs
Outputs from Arthritis Research & Therapy
#2,446
of 3,383 outputs
Outputs of similar age
#261,819
of 432,829 outputs
Outputs of similar age from Arthritis Research & Therapy
#35
of 45 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,383 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,829 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.